Weaver reviews healthcare valuation in 2021

BVWireIssue #234-1
March 2, 2022

healthcare valuation, healthcare, healthcare appraisal, healthcare multiples, multiple

A collection of articles by valuation practitioners at Weaver give a 2021 year in review for healthcare valuations. The articles are organized in three parts: the first part on pandemic-related valuation “tailwinds,” the second part on pandemic-related valuation “headwinds,” and the third part on “enduring topics.” Looking forward, the report states: “In 2022 and beyond, we expect health systems and private equity-backed platforms to continue consolidating to achieve more scale, and to re-invest in digital technology and alternate sites of care. Health care segments negatively affected by the pandemic will likely stabilize in the long run. These are likely to benefit from natural demand growth driven by aging demographics, increased demand for underserved segments such as mental health, and a favorable regulatory and reimbursement environment.” You can download the full report if you click here.
Please let us know if you have any comments about this article or enhancements you would like to see.